Anticipating the Future of the Antibodies Market

The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029.

Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role.

Global Antibodies Market Report Scope:

• Market Size (2029): USD 343.2 billion
• Market Size (2024): USD 183.7 billion
• CAGR (2024 to 2029): 11.31%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: End-user, Product Type, Indication, Application, Region.
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa
• Key Market Players Profiled: Abbott Diagnostics, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, A.G. Scientific, Inc., Bristol-Myers Squibb, AbbVie Inc. Are playing a dominant role in the Antibodies market.

Antibodies are in high demand due to their cost-effectiveness compared to human monoclonal antibodies and their low incidence of side effects, contributing majorly to the global market share. The increasing demand for biosimilar antibodies in treating rheumatoid arthritis and high patient acceptance rates are expected to drive market growth for antibodies. The antibody characteristics are expected to increase their use in various research applications in the coming years due to growing investments in the R&D activities by the market players. The COVID-19 outbreak has created profitable opportunities in the research antibodies market. Various prominent pharmaceutical firms are investing significantly in research and development to develop new vaccines, treatments, and diagnostic tools for therapeutics with the antibodies that propel the market revenue. The growing significance of antibodies in developing new biologic products and the increasing demand for quality control applications in various techniques, such as PCR and electrophoresis, are expected to fuel the market growth opportunities during the forecast period. The increasing [prevalence of chronic autoimmune disorders is raising the demand for antibody drugs, which enhances the opportunities for market expansion. Increasing healthcare expenditure and growing advancements in the healthcare sector are augmenting the expansion of the antibodies market. The growing geriatric population with chronic illness and autoimmune disorders is estimated to boost the demand for antibody therapeutics in the healthcare industry, expanding market size. The rising prevalence of cancer across the world is increasing the research activities for cancer therapeutics, where antibodies play a crucial role. The rising government support initiatives in antibody research activities for cancer, cardiovascular diseases, and various infectious diseases in developing innovative therapeutics drive the global market share.

The presence of stringent regulatory requirements can hinder the market growth of antibodies due to their complex nature. These molecules require extensive clinical trials, leading to delays and increased costs. The high costs associated with research, clinical trials, and manufacturing, especially for monoclonal antibodies, can hamper the market, especially for smaller companies and research institutions. Competition from biosimilar antibodies, similar but not identical to existing antibodies, can reduce market share for original antibodies.

Browse full details of the report @https://www.marketdataforecast.com/market-reports/antibodies-market

Key Insights from The Report:
• Based on product, the monoclonal antibodies segment led the market and accounted for the largest share of the global market in 2023.
• Based on application, the medical and experimental segment captured highest share of the global market in 2023.
• Based on Indication, the cancer segment dominated the market in 2023.
• Based on end-user, the Cancer indication type segment occupied the majority of the global market share in 2023.
• North America dominated the Antibodies market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• AMD Antibodies Market, Abbott Diagnostics, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, A.G. Scientific, Inc. are dominated the Antibodies market.

SEGMENTATION INCLUDED IN THIS REPORT:
By Product Type:
• Monoclonal Antibodies
o Murine
o Chimeric
o Humanized
o Human
• Polyclonal Antibodies
o Type I
o Type II
o Type III
o Type IV
o Type V
o Type VI
o Type VII
o Type VIII
• Anti-body drug complexes
o Immunogen Technology
o Seattle Genetics Technology
o Immunomedics Technology
By Indication:
• Cancer
• Autoimmune Diseases
• Infectious Diseases
• Cardiovascular Diseases
• CNS Disorders
• Others (Inflammatory, Microbial Diseases, & Others)
By Application:
• Medical
• Experimental
• Western blot
• ELISA
• Radioimmune Assays
• Immunofluorescence
• Others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)
By End-User:
• Hospitals/Clinics
• Research Institute
• Diagnostics laboratories
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:

North America Antibodies Market Research Report - Segmented By Product Type, Indication, End User, Application & By Country (U.S, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) - https://www.marketdataforecast.com/market-reports/north-america-antibodies-market
Europe Antibodies Market Research Report - Segmented By Product Type, Indication, End User, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) -https://www.marketdataforecast.com/market-reports/europe-antibodies-market
APAC Antibodies Market Research Report - Segmented By Product Type, Indication, End User, Application & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) - https://www.marketdataforecast.com/market-reports/asia-pacific-antibodies-market
Latin America Antibodies Market Research Report - Segmented By Product Type, Indication, End User, Application & By Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast (2023 to 2028) -https://www.marketdataforecast.com/market-reports/latin-america-antibodies-market
Middle East & Africa Antibodies Market Research Report - Segmented By Product Type, Indication, End User, Application & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and Rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast from 2023 to 2028 -https://www.marketdataforecast.com/market-reports/Middle-East-and-Africa-antibodies-market

TABLE OF CONTENTS:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Monoclonal Antibodies
5.1.1.1 Murine
5.1.1.2 Chimeric
5.1.1.3 Humanized
5.1.1.4 Human
5.1.2 Polyclonal Antibodies
5.1.2.1 Type I
5.1.2.2 Type II
5.1.2.3 Type III
5.1.2.4 Type IV
5.1.2.5 Type V
5.1.2.6 Type VI
5.1.2.7 Type VII
5.1.2.8 Type VIII
5.1.3 Antibody-Drug Complexes
5.1.3.1 Immunogen Technology
5.1.3.2 Seattle Genetics Technology
5.1.3.3 Immunomedics Technology
5.2 By Indication
5.2.1 Cancer
5.2.2 Autoimmune Diseases
5.2.3 Infectious Diseases
5.2.4 Cardiovascular Diseases
5.2.5 CNS Disorders
5.2.6 Others (Inflammatory, Microbial Diseases, & Other)
5.3 End User
5.3.1 Hospitals/Clinics
5.3.2 Research Institute
5.3.3 Diagnostic Laboratories
5.4 Application
5.4.1 Medical
5.4.2 Experimental
5.4.2.1 Western Blot
5.4.2.2 ELISA
5.4.2.3 Radioimmune Assays
5.4.2.4 Immunofluorescence
5.4.2.5 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Pipeline Product Analysis
7.1 Overview
7.2 Pipeline Development Landscape
7.3 Molecular Targets in the Pipeline
7.4 Clinical Trials
7.4.1 Clinical Trial Duration by Stage of Development, Indication, Molecule Type, and Molecular Target
7.4.2 Clinical Trial Size by Stage of Development, Indication, Molecule Type, and Molecular Target
7.5 Key Trends in Antibodies Development
7.5.1 Targeted Therapies
7.6 Promising Antibodies in Pipeline
7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Antibodies
8. Strategic Analysis
8.1 PESTLE analysis
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Legal
8.1.6 Environmental
8.2 Porter's Five analysis
8.2.1 Bargaining Power of Suppliers
8.2.2 Bargaining Power of Consumers
8.2.3 Threat of New Entrants
8.2.4 Threat of Substitute Products and Services
8.2.5 Competitive Rivalry within the Industry
9. Market Leaders' Analysis
9.1 Abbott Diagnostics (U.S.)
9.1.1 Overview
9.1.2 Product Analysis
9.1.3 Financial analysis
9.1.4 Recent Developments
9.1.5 SWOT analysis
9.1.6 Analyst View
9.2 Novartis AG (Switzerland)
9.3 Pfizer Inc. (U.S.)
9.4 Thermo Fisher Scientific Inc. (U.S.)
9.5 Eli Lilly and Company (U.S.)
9.6 A.G. Scientific, Inc. (U.S.)
9.7 Bristol-Myers Squibb (U.S.)
9.9 F. Hoffmann-La Roche Ltd. (Switzerland)
9.10 AbbVie Inc. (U.S.)
10. Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations, and Joint Ventures
10.4 New Product Launches
11. Expert Opinions
11.1 Market Outlook
11.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

Contact Us:
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.